drugset / Trial / NCT00304616
SWitching to Abilify Trial (SWAT)
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy, safety and tolerance of an 12 and 26-week aripiprazole administration
Timeline
- Start
- 2004-10
- Primary completion
- 2006-06
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | Oral |
| Subject | Aripiprazole | Other / unclassified | 30 mg | Oral |
| Background | Amisulpride | Small molecule | — | — |
| Background | Olanzapine | Small molecule | — | — |
| Background | Quetiapine | Small molecule | — | — |
| Background | Risperidone | Other / unclassified | — | — |